A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada
Biliary tract cancers (BTC) are rare and aggressive tumors with poor prognosis. Radical surgery offers the best chance for cure; however, most patients present with unresectable disease, and among those receiving curative-intent surgery, recurrence rates remain high. While other locoregional therapi...
Main Authors: | Ravi Ramjeesingh, Prosanto Chaudhury, Vincent C. Tam, David Roberge, Howard J. Lim, Jennifer J. Knox, Jamil Asselah, Sarah Doucette, Nirlep Chhiber, Rachel Goodwin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/30/8/517 |
Similar Items
-
Neoadjuvant Therapy for Extrahepatic Biliary Tract Cancer: A Propensity Score-Matched Survival Analysis
by: Junya Toyoda, et al.
Published: (2023-04-01) -
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review
by: Changhoon Yoo, et al.
Published: (2021-04-01) -
Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm
by: Sakti Chakrabarti, et al.
Published: (2020-07-01) -
Recent Advances in the Mechanism Research and Clinical Treatment of Anti-Angiogenesis in Biliary Tract Cancer
by: Yue Wang, et al.
Published: (2021-10-01) -
Third-Line Palliative Systemic Therapy for Advanced Biliary Tract Cancer: Multicentre Review of Patterns of Care and Outcomes
by: Simon Gray, et al.
Published: (2023-06-01)